Solid Biosciences to Participate at the Jefferies Global Healthcare Conference

Core Insights - Solid Biosciences Inc. is participating in the Jefferies Global Healthcare Conference on June 4, 2025, with a fireside chat featuring the President and CEO, Bo Cumbo, and Chief Medical Officer, Gabriel Brooks [1][2] Company Overview - Solid Biosciences is focused on developing precision genetic medicines targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich's ataxia, and catecholaminergic polymorphic ventricular tachycardia [3] - The company is advancing a diverse pipeline of gene therapy candidates and innovative libraries of genetic regulators aimed at improving gene therapy delivery across the industry [3] - Solid Biosciences was founded by individuals directly impacted by Duchenne, emphasizing its mission to enhance the daily lives of patients with rare diseases [3]